Published in Parasite Immunol on September 01, 1982
Human babesiosis. Infect Dis Clin North Am (2008) 2.12
Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. Infect Immun (1999) 1.13
Interaction between murine natural killer cells and trypanosomes of different species. Infect Immun (1984) 0.82
Possible importance of macrophage-derived mediators in acute malaria. Infect Immun (1981) 3.58
Protection of mice against Babesia and Plasmodium with BCG. Nature (1976) 3.01
Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun (1983) 2.59
Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature (1974) 2.55
Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology (1977) 2.28
Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun (1991) 2.16
Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg (1996) 2.13
Efficiency of inspection procedures for the detection of tuberculous lesions in cattle. Aust Vet J (1990) 2.05
A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle. Aust Vet J (1990) 2.04
Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet (1978) 1.91
Purification and characterization of major antigens from a Mycobacterium bovis culture filtrate. Infect Immun (1991) 1.84
A comparison of the interferon gamma assay with the absorbed ELISA for the diagnosis of Johne's disease in cattle. Aust Vet J (1992) 1.81
Head extension and laryngeal view during laryngoscopy with cervical spine stabilization maneuvers. Anesthesiology (1994) 1.64
Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J Immunol (1986) 1.58
Gas chromatographic method for the determination of fluconazole, a novel antifungal agent, in human plasma and urine. J Chromatogr (1986) 1.58
The effect of gliotoxin upon macrophage function. Int J Immunopharmacol (1986) 1.50
Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology (1988) 1.47
The current place of learning objectives in paediatrics. Med Educ (1989) 1.46
Different effector cell types in antibody-dependent cell-mediated cytotoxicity. Nature (1975) 1.45
Specific and non-specific immunity to haemoprotozoa. Am J Trop Med Hyg (1977) 1.43
When in doubt, take it out ... the epidural catheter. Anaesthesia (1989) 1.38
Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol (1994) 1.32
Purification of a major Mycobacterium bovis antigen for the diagnosis of bovine tuberculosis. Scand J Immunol (1989) 1.32
Macrophage heterogeneity. Vox Sang (1979) 1.28
Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell Immunol (1988) 1.27
Free oxygen radical generators as antimalarial drugs. Lancet (1983) 1.26
Free radical-induced pathology. Med Res Rev (1985) 1.26
The in vitro bactericidal activity of peritoneal and spleen cells from Listeria-resistant and -susceptible mouse strains. Cell Immunol (1986) 1.25
In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect Immun (1992) 1.21
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J Exp Med (1984) 1.20
Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens. Scand J Immunol (1994) 1.20
The gamma-interferon assay for diagnosis of bovine tuberculosis in cattle: conditions affecting the production of gamma-interferon in whole blood culture. Aust Vet J (1992) 1.16
Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition. Infect Immun (1977) 1.14
Serological reactivity to Mycobacterium bovis protein antigens in cattle. Vet Microbiol (1992) 1.13
The pathophysiology of canine babesiosis: new approaches to an old puzzle. J S Afr Vet Assoc (1994) 1.11
Epitope mapping of the Mycobacterium bovis secretory protein MPB70 using overlapping peptide analysis. J Gen Microbiol (1990) 1.08
Oxygen-derived free radicals in the pathogenesis of parasitic disease. Adv Parasitol (1986) 1.08
Serum tumor necrosis factor associated with malaria in patients in the Solomon Islands. Trans R Soc Trop Med Hyg (1991) 1.03
An ELISA for the detection of anergic tuberculous cattle. Aust Vet J (1989) 1.03
Immunity to intra-erythrocytic protoza. Lancet (1975) 1.01
Immunopathophysiology of Babesia bovis and Plasmodium falciparum infections. Parasitol Today (1988) 1.01
Intra-erythrocytic death of the parasite in mice recovering from infection with Babesia microti. Parasitology (1977) 0.99
Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J Immunol (1989) 0.99
Effects of endotoxin on the histology of intact and athymic mice infected with Plasmodium vinckei petteri. J Pathol (1980) 0.99
Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice. Br J Exp Pathol (1989) 0.99
An analysis of cellular proliferation, and synthesis of lymphokines and specific antibody in vitro by leucocytes from immunized cattle. Vet Immunol Immunopathol (1988) 0.97
Demonstration of a lipopolysaccharide-induced cytostatic effect on malarial parasites. Infect Immun (1981) 0.95
Macrophages from Babesia and malaria infected mice are primed for monokine release. Parasite Immunol (1984) 0.94
Soluble Mycobacterium bovis protein antigens: studies on their purification and immunological evaluation. Vet Microbiol (1994) 0.94
In vitro induction of nitric oxide by an extract of Plasmodium falciparum. J Infect (1996) 0.94
Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. Am J Trop Med Hyg (1994) 0.93
Mapping of the T and B cell epitopes of the Mycobacterium bovis protein, MPB70. Immunol Cell Biol (1990) 0.90
Antibody-dependent cell-mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates. Parasite Immunol (2001) 0.90
Assessing quality of life in Mexican-American children with asthma: impact-on-family and functional status. J Pediatr Psychol (2000) 0.90
Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klin Wochenschr (1982) 0.90
Oxidative stress and protective mechanisms in erythrocytes in relation to Plasmodium vinckei load. Proc Natl Acad Sci U S A (1985) 0.90
Activity of mouse macrophages purified by adherence to, and removal from, a plastic surface. J Immunol Methods (1979) 0.89
Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection. Infect Immun (1984) 0.89
Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis. J Infect Dis (1994) 0.89
Sinus bradycardia associated with traumatic haemothorax. Br J Anaesth (1994) 0.88
Haemophilus influenzae meningitis in school-aged children. JAMA (1982) 0.88
Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep. Parasite Immunol (1997) 0.88
Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease. Parasite Immunol (1999) 0.88
Inflammatory fatigue and sickness behaviour - lessons for the diagnosis and management of chronic fatigue syndrome. J Affect Disord (2012) 0.88
Propofol infusion for the treatment of status epilepticus. Lancet (1988) 0.87
High mobility group box 1 (HMGB1) protein: possible amplification signal in the pathogenesis of falciparum malaria. Trans R Soc Trop Med Hyg (2005) 0.87
Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii. Infect Immun (1979) 0.87
Activity of divicine in Plasmodium vinckei-infected mice has implications for treatment of favism and epidemiology of G-6-PD deficiency. Br J Haematol (1984) 0.87
Detection of short-chain carbonyl products of lipid peroxidation from malaria-parasite (Plasmodium vinckei)-infected red blood cells exposed to oxidative stress. Biochem J (1988) 0.86
Cytokine gene expression in sheep following experimental infection with various strains of Corynebacterium pseudotuberculosis differing in virulence. Vet Res (1997) 0.86
Immune responses associated with protection in sheep vaccinated with a recombinant antigen from Taenia ovis. Parasite Immunol (1996) 0.86
The inhibition of Plasmodium falciparum growth in vitro by sera from mice infected with malaria or treated with TNF. Parasitology (1990) 0.86
Antigenic competition in a multivalent foot rot vaccine. Vaccine (1994) 0.86
Toxicity of certain products of lipid peroxidation to the human malaria parasite Plasmodium falciparum. Biochem Pharmacol (1987) 0.86
Juvenile Fasciola hepatica are resistant to killing in vitro by free radicals compared with larvae of Schistosoma mansoni. Parasite Immunol (2000) 0.86
Protection of mice against Babesia microti with cord factor, COAM, zymosan, glucan, Salmonella and Listeria. Parasite Immunol (1979) 0.85
Radical-mediated damage to parasites and erythrocytes in Plasmodium vinckei infected mice after injection of t-butyl hydroperoxide. Clin Exp Immunol (1984) 0.85
Role of TNF in cerebral malaria. Lancet (1991) 0.85
Analysis of ovine IL-1 beta production in vivo and in vitro by enzyme immunoassay and immunohistochemistry. Vet Immunol Immunopathol (1997) 0.85
Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants. Vet Immunol Immunopathol (1998) 0.84
SLE and malaria: another look at an old idea. Parasitol Today (1990) 0.84
Genetic control of Propionibacterium acnes-induced protection of mice against Babesia microti. Infect Immun (1982) 0.84
Characterisation of monoclonal antibodies to ovine interleukin-6 and the development of a sensitive capture ELISA. Vet Immunol Immunopathol (2000) 0.84
Compliance with oral theophylline therapy in asthmatic children. Ann Allergy (1985) 0.84
Protection of mice against haemoprotozoan Babesia microti with Brucella abortus strain 19. Clin Exp Immunol (1978) 0.84
Expression of ovine gamma interferon in Escherichia coli and Corynebacterium glutamicum. Appl Environ Microbiol (1994) 0.83
Nitric oxide in cerebral malaria. J Infect Dis (1995) 0.83
The induction of tyrosine aminotransferase activity and its use as an indirect assay for endotoxin in mice infected with Plasmodium vinckei petteri. Int J Parasitol (1982) 0.83
Immunopathophysiology of babesial infections. Trans R Soc Trop Med Hyg (1989) 0.83
Bm86 antigen induces a protective immune response against Boophilus microplus following DNA and protein vaccination in sheep. Vet Immunol Immunopathol (1999) 0.83
The ratio of reactive nitrogen intermediates to tumour necrosis factor and clinical outcome of falciparum malaria disease. Trans R Soc Trop Med Hyg (1998) 0.83
Immunological parameters associated with antigenic competition in a multivalent footrot vaccine. Vaccine (1995) 0.83
Implementation of individualized patient education for Hispanic children with asthma. Patient Educ Couns (1996) 0.83
Influence of antigens and adjuvants on the production of gamma-interferon and antibody by ovine lymphocytes. Immunol Cell Biol (1990) 0.82
Cloning and sequencing of the ovine gamma-interferon gene. Aust Vet J (1991) 0.82
Cloning, sequencing, expression and inflammatory activity in skin of ovine interleukin-8. Immunol Cell Biol (1994) 0.82
Effect of splenectomy on production of interferon and colony-stimulating factor in Listeria monocytogenes-infected mice. Infect Immun (1984) 0.82